Bayer's Mammography Screening Injection Approved by FDA
23 Juin 2023 - 8:36PM
Dow Jones News
By Sabela Ojea
Bayer said Friday the Food and Drug Administration has approved
its Ultravist injection to visualize breast lesions as an adjunct
to mammographies or ultrasounds.
The pharmaceutical company said Ultravist-300 and -370 gives
physicians a new imaging option beyond conventional
mammographies.
"The new FDA-approved indication aligns with the recent
increased focus on supplemental imaging needs for women at a higher
risk for breast cancer," Bayer said.
Ultravist is an injection for intravenous and intra-arterial
use.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 23, 2023 14:21 ET (18:21 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Bayer Aktiengesellschaft (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Bayer Aktiengesellschaft (PK)